Evaluation of safety and efficacy of PROMETRIUM [progesterone] capsules in induction of secretory conversion of endometrium and withdrawal bleeding in subjects with secondary amenorrhea.

Trial Profile

Evaluation of safety and efficacy of PROMETRIUM [progesterone] capsules in induction of secretory conversion of endometrium and withdrawal bleeding in subjects with secondary amenorrhea.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2010

At a glance

  • Drugs Conjugated estrogens; Progesterone
  • Indications Amenorrhoea
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 03 Nov 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Actual patient number (240) added as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top